![James D. Luterman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James D. Luterman
Profile
James D.
Luterman worked as the Executive Vice President-Research & Development at OvaScience, Inc. from 2016 to 2018.
He received his undergraduate degree from Bucknell University and his doctorate degree from Rutgers State University of New Jersey.
Former positions of James D. Luterman
Companies | Position | End |
---|---|---|
OvaScience, Inc.
![]() OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | - |
Training of James D. Luterman
Bucknell University | Undergraduate Degree |
Rutgers State University of New Jersey | Doctorate Degree |
Experiences
Positions held
Linked companies
Private companies | 1 |
---|---|
OvaScience, Inc.
![]() OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- James D. Luterman